Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - ALTAIR NANOTECHNOLOGIES INCex99-1.htm
EX-10.1 - EXHIBIT 10.1 - ALTAIR NANOTECHNOLOGIES INCex10-1.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC  20549
 

 
FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (date of earliest event reported):   June 3, 2011
         
Altair Nanotechnologies Inc.
(Exact Name of Registrant as Specified in its Charter)
         
Canada
 
1-12497
 
33-1084375
(State or other jurisdiction of
 
(Commission
 
(IRS Employer
incorporation or organization)
 
File Number)
 
Identification No.)
         
204 Edison Way
     
Reno, NV
   
89502
(Address of Principal Executive Offices)
   
(Zip Code)
         
   
Registrant's Telephone Number, Including Area Code:
   
   
(801) 858-3750
   
         
N/A
(Former name, former address, and formal fiscal year, if changed since last report)
 
 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):
 
[  ]
Written  communications  pursuant to Rule 425 under the  Securities Act (17 CFR 230.425)
[  ]
Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]
Pre-commencement  communications  pursuant to Rule  14d-2(b)  under the Exchange Act (17 CFR 240.14d-2(b))
[  ]
Pre-commencement  communications  pursuant to Rule  13e-4(c)  under the Exchange Act (17 CFR 240.13e-4(c)
 
 
 

 
 
TABLE OF CONTENTS

Item 1.01  
Entry into Material Definitive Agreement
   
Item 7.01
Regulation FD Disclosure
   
Item 9.01
Financial Statements and Exhibits

SIGNATURES

EXHIBIT INDEX

EX. 10.1
Third Amendment to Share Subscription Agreement
   
EX. 99.1
Press Release
 
 
 
2

 
 
Item 1.01   Entry into Material Definitive Agreement

On June 3, 2011, Altair Nanotechnologies Inc. (the “Company”) and Canon Investment Holdings Limited (“Canon”) entered into a Third Amendment to Share Subscription Agreement (the “Third Amendment”) to the Share Subscription Agreement dated September 20, 2010 as previously amended by the First Amendment to Share Subscription Agreement dated as of February 16, 2011 and the Second Amendment to Share Subscription Agreement dated May 17, 2011 (the “Agreement”) between the Company and Canon. The purpose of the Third Amendment is to extend the deadline and closing date under the Agreement to June 20, 2011. The foregoing description of the Third Amendment is a summary only and is qualified in its entirety by the Third Amendment, a copy of which is attached to this Current Report on Form 8-K as Exhibit 10.1.
 
Item 7.01   Regulation FD Disclosure.

On June 3, 2011 the Company issued a press release entitled “Altair Nanotechnologies Announces Additional Extension of Share Subscription Agreement with Canon Investment Holdings”.  A copy of the press release is furnished as Exhibit 99.1 to this Current Report.

The information set forth in this Item 7.01 and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Securities Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01   Financial Statements and Exhibits.

(d)           Exhibits.

10.1           Third Amendment to Share Subscription Agreement dated June 3, 2011 by and between Altair Nanotechnologies Inc. and Canon Investment Holdings Limited.

99.1           Press release issued by Altair Nanotechnologies Inc. dated June 3, 2011 entitled “Altair Nanotechnologies Announces Additional Extension of Share Subscription Agreement with Canon Investment Holdings”.
 
 
 
3

 

SIGNATURES

 Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
Altair Nanotechnologies Inc.
 
       
Dated: June 3, 2011
By:
/s/ John Fallini
 
   
John Fallini, Chief Financial Officer
 
 
 
 
 
4